We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Warning Letter Despite Satisfactory Response to Form 483
FDA Issues Warning Letter Despite Satisfactory Response to Form 483
April 5, 2007
The FDA told RyMed Technologies during a meeting that the firm’s initial response to a Form 483 regarding alleged cGMP violations satisfied the agency’s concerns, according to the firm.